Immunoassays Market Research Reports & Industry Analysis
An immunoassay is one of the most effectual analytical tests performed due to its specificity, sensitivity and versatility. To test the concentration of a substance within a solution, immunoassay tests use specific antibodies that will react with antigens in the solution. Monoclonal antibodies provide accurate test results and are the most common antibodies used in immunoassay testing due to their ability to bind to one site of any particular molecule. To get an accurate result, the specific antibody must have a high affinity to the antigen being tested for. The number of antigens and antibodies present in the tested solution is measured. This measurement tells how much of the analyte is located within the sample and how concentrated it is.
One of the most widely used immunoassay applications for the detection of infectious disease is the enzyme-linked immunosorbant assay (ELISA). Because of its high sensitivity, the ELISA was the first screening test widely used for HIV.
Immunoassays are significant tests that perform an array of functions in conventional medicine. While it is used primarily to test for things such as HIV in the body, the test can also be used to discover new ways to test for other diseases and conditions that don’t have a direct scientific diagnostic method.
Immunoassays Industry Research & Market Reports
-
2024 Global: Cell Viability Assays Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Protein Assays Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Lateral Flow Assay Components Market 2024-2028
... on the lateral flow assay components market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
2024 POC/Decentralized Clinical Chemistry and Immunodiagnostic Testing Market: Country Supplier Shares, Test Volume and Sales Segment Forecasts
... requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of ... Read More
-
2024 Global Hepatitis A, B, C, D, E Diagnostics Market: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers
... The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The ... Read More
-
2024 UK Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers
... detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV ... Read More
-
2024 Italy Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers
... detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, ... Read More
-
2024 Germany Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers
... detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, ... Read More
-
2024 Global Clinical Chemistry and Immunodiagnostics Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 100 Tests, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities
... technology assessment study from LeadingMarketResearch.com was designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. ; The report explores future trends in the U.S., five ... Read More
-
2024 Global Immunodiagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers
... of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future trends in the U.S., Europe and Asia; provides ... Read More
-
2024 Europe Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts - AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas Vaginalis
... sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the France, Germany, Italy, ... Read More
-
2024 US Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers
... detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV ... Read More
-
2024 France Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers
... detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, ... Read More
-
Africa IVD Market Size, Share, Forecast, & Trends Analysis by Offering, Technology (Immunoassay, PoC, Molecular Diagnostics, Coagulation) Application (Infectious Diseases, Diabetes, Oncology) Diagnostic Approach (Lab, OTC, PoCT) End User- Forecast to 2031
... market is expected to reach $1.65 billion by 2031, at a CAGR of 3.1% from 2024 to 2031. With extensive primary and secondary research and in-depth analysis of the market scenario, the report studies the ... Read More
-
Global Functional Genomics Market Size study, by Product (Kits Assays, Instruments), by Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Other Technologies), by Application (Epigenomics, Transcriptomics, Proteomics, Metabolomics), by End-User (Academic and Research Institutions, Biotechnology and Biopharmaceutical Companies, Others) and Regional Forecasts 2022-2032
... Biotechnology and Biopharmaceutical Companies, Others) and Regional Forecasts 2022-2032 Global Functional Genomics Market was valued at USD 9.54 billion in 2023 and is anticipated to project robust growth in the forecast period with a compound ... Read More
-
Biomarker Technologies Market Report by Test Type (Solid Biopsy, Liquid Biopsy), Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others), Product (Consumables, Assay, Reagent, Instruments), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others), Application (Drug Discovery, Clinical Diagnostics, Personalized Medicine), and Region 2024-2032
... Immunoassay, and Others), Application (Drug Discovery, Clinical Diagnostics, Personalized Medicine), and Region 2024-2032 The global biomarker technologies market size reached US$ 40.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ ... Read More
-
ADME Toxicology Testing Market Report by Technology (Cell Culture, High Throughput Screening, Molecular Imaging, OMICS Technology, and Others), Product Type (Instruments, Software Solutions, Assay Systems, Reagents, and Others), Method (In-Vivo, In-Vitro, In-Silica, and Others), Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others), and Region 2024-2032
... (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others), and Region 2024-2032 The global ADME toxicology testing market size reached US$ 9.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.1 ... Read More
-
Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032
... Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032 The global companion diagnostics market size reached US$ 6.7 Billion in 2023. ... Read More
-
Veterinary Reference Laboratory Market Report by Technology (Clinical Chemistry, Hematology, Immunodiagnostics, Molecular Diagnostics, and Others), Application (Clinical Pathology, Toxicology, Productivity Testing, and Others), Animal Type (Livestock Animals, Companion Animals), and Region 2024-2032
... reference laboratory market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2032, exhibiting a growth rate (CAGR) of 10.2% during 2024-2032. The market ... Read More
-
Oxidative Stress Assay Market Report by Product (Reagents and Consumables, Instruments, Services), Technology (ELISA (Enzyme-Linked Immunosorbent Assay), Flow Cytometry, Chromatography, Microscopy, High-Content Screening, Label-Free Detection, and Others), Test Type (Indirect Assays, Antioxidant Capacity Assays, Enzyme-Based Assays, Reactive Oxygen Species-Based Assays), End User (Pharmaceutical Industry, Research Institutes, and Others), and Region 2024-2032
... Assays, Reactive Oxygen Species-Based Assays), End User (Pharmaceutical Industry, Research Institutes, and Others), and Region 2024-2032 The global oxidative stress assay market size reached US$ 865.3 Million in 2023. Looking forward, IMARC Group expects the ... Read More
-
Veterinary Rapid Test Global Market Report 2024
... Bacterial Diseases; Parasitic Diseases; Allergies5) By End-User: Veterinary Hospitals And Clinics; Homecare SettingsCovering: Thermo Fisher Scientific Inc.; Zoetis Inc.; bioMérieux SA; IDEXX Laboratories Inc.; Sysmex Corporation Veterinary Rapid Test Global Market Report 2024 from The ... Read More
-
Global IVD Raw Materials Market - Focused Insights 2024-2029
... Microfluid Technology Microfluidic technology significantly advances diagnostic testing by miniaturizing sample analysis processes into tiny flow channels. This innovation enables high-throughput, rapid, and automated diagnostic testing, offering substantial benefits in efficiency and accuracy. By precisely ... Read More
-
India Host Cell Protein Testing Market Research Report Information by Product Type (PCR-based assays, ELISA-based assays, mass spectrometry-based assays and others), by End User (Contract Research Organizations, Biopharmaceutical Companies, and Others) – Industry Forecast to 2032
... 2032 It is projected that the India host cell protein testing market will grow at a robust rate of 99.12% over the course of the review year. During the biotherapeutic manufacturing process, the host organism ... Read More
-
Europe In-Vitro Diagnostics Market Forecast Report by Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, Others) Product (Services, Instruments, Reagents) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, Others) End User (Hospitals, Laboratories, Home - Care, Others) Countries and Company Analysis, 2024-2032
... Product (Services, Instruments, Reagents) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, Others) End User (Hospitals, Laboratories, Home - Care, Others) ... Read More
-
Autoimmune Disease Diagnosis
... by 2030, growing at a CAGR of 5.3% over the period 2023-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record 5.6% CAGR and reach US$4.1 Billion by ... Read More